Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 8 minute read General business news GlobalData (LON: DATA) posts £322m in FY2025 revenue as AI Hub hits 90% customer adoption ahead of Main Market debut GlobalData FY2025 results show 13% revenue growth to £322m but just 1% organically. AI Hub at 90% adoption and Main Market listing set up a pivotal 2026. Read more. byVenkateshMarch 4, 2026